Streetbeat News

Stock Prices

TSLA

Wedbush analyst Daniel Ives lowered Tesla's price target from $350 to $315 and removed it from the Best Ideas List after a disappointing Q4 report and vague 2024 guidance. Ives criticized Tesla's earnings call and suggested a 10-point plan to improve share performance, including a $10 billion buyback, a new 'X Holding' structure for AI initiatives, maintaining automotive margins, hosting an AI Day, securing outside capital for X/Twitter, a new CEO compensation package, setting a Model 2 production timeline, returning to formal guidance, AI acquisitions, and setting long-term AI targets.

Portfolio Pulse from Chris Katje

January 26, 2024 | 6:15 pm

HUM

Stephens & Co. analyst Scott Fidel has maintained an Overweight rating on Humana (NYSE:HUM) but reduced the price target from $550 to $430.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:09 pm

GNTX

Gentex Corp (NASDAQ:GNTX) shares rose after reporting Q4 financial results surpassing expectations. Sales increased 19% Y/Y to $589.1 million, exceeding analyst estimates of $560.8 million. EPS was $0.50, beating the $0.44 consensus. Automotive net sales climbed to $578.7 million, with auto-dimming mirror shipments up 12%. Gross profit margin improved to 34.5% from 31.2% due to price increases and cost recoveries. Operating income jumped 41% Y/Y to $132.8 million. The company repurchased 2.2 million shares and ended the quarter with $240.8 million in cash. FY24 revenue is projected between $2.45 billion and $2.55 billion, aligning with consensus estimates, and FY25 revenue is forecasted at $2.65 billion to $2.75 billion. CEO Steve Downing outlined plans for further gross margin improvements. GNTX shares surged 7.202% to $34.13.

Portfolio Pulse from Lekha Gupta

January 26, 2024 | 6:07 pm

GM

HTGC

JEPI

TOST

On CNBC's Halftime Report, analysts shared their final trades, which included Toast Inc. (TOST), JPMorgan Equity Premium Income ETF (JEPI), Hercules Capital (HTGC), and General Motors (GM). These recommendations provide insights into the analysts' views on these assets.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:07 pm

LKFN

Stephens & Co. analyst Terry McEvoy has maintained an Equal-Weight rating on Lakeland Financial (NASDAQ:LKFN) and increased the price target from $67 to $70.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:06 pm

USO

The latest Baker Hughes rig count report shows an increase in oil rigs by 2 and a decrease in gas rigs by 1. This data is a key indicator of future production levels and can influence oil prices and related stocks.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:05 pm

FFIN

Stephens & Co. analyst Matt Olney has maintained an Equal-Weight rating on First Finl Bankshares (NASDAQ:FFIN) and increased the price target from $30 to $32.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:01 pm

GRFS

Grifols has filed a lawsuit in the U.S. District Court for the Southern District of New York against Daniel Yu, Gotham City Research, General Industrial Partners, Cyrus De Weck, and their affiliates. The lawsuit seeks to address financial and reputational damages suffered by Grifols and its stakeholders due to the defendants' actions. The complaint alleges that the defendants took a large short position in Grifols and then published a report with false statements about the company's accounting, disclosures, financial condition, and integrity. Grifols is seeking both injunctive and monetary relief and aims to hold the defendants fully accountable for their alleged wrongful conduct.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:01 pm

A

BIO

DHR

TMO

Lifesciences and medical equipment stocks are experiencing an uptick in share prices after Sartorius reported robust earnings. This positive sentiment is likely influencing the market perception of related companies in the sector.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:00 pm

CFR

Stephens & Co. analyst Matt Olney has maintained an Equal-Weight rating on Cullen/Frost Bankers (NYSE:CFR) and increased the price target from $116 to $117.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 5:57 pm